SCHEMBL3668600

SCHEMBL3668600

O=C(NC1CCN(C(I)c2ccccc2)CC1)c1cc2cc(OC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)ccc2o1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 2/20 0.52
SIGMAR1 Q99720 2/20 0.50
FFAR1 O14842 1/20 0.47
MCHR1 Q99705 3/20 0.46
ACHE P22303 2/20 0.46
UBE2M P61081 1/20 0.45
DCUN1D1 Q96GG9 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SLC6A5 Q9Y345 1/20 0.44
HRH1 P35367 1/20 0.44
CCR3 P51677 1/20 0.44
KCNH2 Q12809 1/20 0.44
MKNK2 Q9HBH9 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649756 0.91 DRD4 (0.59) DRD4SIGMAR1MCHR1ACHEUBE2M
SCHEMBL3663733 0.86 SLC6A4 (0.43) DRD4FFAR1MCHR1ACHESLC6A5
SCHEMBL3663596 0.85 PRKAA2 (0.49) MCHR1ACHEKDM4EALDH1A1HPGD
SCHEMBL649755 0.82 SLC6A5 (0.54) DRD4SIGMAR1MCHR1ACHEKDM4E
SCHEMBL3665644 0.82 CHRM4 (0.43) MCHR1
SCHEMBL4430440 0.80 DRD4 (0.59) DRD4SIGMAR1MCHR1UBE2MDCUN1D1
SCHEMBL649902 0.79 SIGMAR1 (0.56) SIGMAR1MCHR1ACHEKDM4EALDH1A1
SCHEMBL647657 0.79 ACHE (0.59) DRD4SIGMAR1MCHR1ACHEKDM4E
SCHEMBL648322 0.78 DRD4 (0.52) DRD4SIGMAR1MCHR1ACHEKDM4E
SCHEMBL648725 0.78 CHRM4 (0.60) MCHR1ACHEKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231600-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS Rigel Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009065131-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-05-22 WO claimed